These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis. You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709 [TBL] [Abstract][Full Text] [Related]
14. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells. Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235 [TBL] [Abstract][Full Text] [Related]
16. Bone Marrow and Wharton's Jelly Mesenchymal Stromal Cells are Ineffective for Myocardial Repair in an Immunodeficient Rat Model of Chronic Ischemic Cardiomyopathy. Tang XL; Nasr M; Zheng S; Zoubul T; Stephan JK; Uchida S; Singhal R; Khan A; Gumpert A; Bolli R; Wysoczynski M Stem Cell Rev Rep; 2023 Oct; 19(7):2429-2446. PubMed ID: 37500831 [TBL] [Abstract][Full Text] [Related]
17. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia. Reiter J; Drummond S; Sammour I; Huang J; Florea V; Dornas P; Hare JM; Rodrigues CO; Young KC Respir Res; 2017 Jul; 18(1):137. PubMed ID: 28701189 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats. Xie Y; Chen F; Jia L; Chen R; Zhang VW; Zhong X; Wang D J Cell Mol Med; 2021 Sep; 25(17):8558-8566. PubMed ID: 34322990 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury. Ahn SY; Park WS; Kim YE; Sung DK; Sung SI; Ahn JY; Chang YS Exp Mol Med; 2018 Apr; 50(4):1-12. PubMed ID: 29650962 [TBL] [Abstract][Full Text] [Related]
20. Dual production of human mesenchymal stromal cells and derived extracellular vesicles in a dissolvable microcarrier-based stirred culture system. Bandarra-Tavares H; Franchi-Mendes T; Ulpiano C; Morini S; Kaur N; Harris-Becker A; Vemuri MC; Cabral JMS; Fernandes-Platzgummer A; da Silva CL Cytotherapy; 2024 Jul; 26(7):749-756. PubMed ID: 38506771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]